Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Liu, MD
Celgene
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitatsklinik Fur Innere Medizin
Innsbruck, Austria
- Akh Linz
Linz, Austria
- Universitatsklinik Der Pmu
Salzburg, Austria
- Allgemeines Krankenhaus Wien
Vienna, Austria
- Medizinische Abteilung-Zentrum Fur Onkologie Und Hamatologie
Vienna, Austria
- Clearview Cancer Institute Oncology Specialties, P.C
Huntsville, Alabama, United States
- Horizon Oncology Center
Lafayette, Indiana, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Mount Sinai School of Medicine
New York, New York, United States
- the West Clinic
Memphis, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Dec 2012
- Primary completion
- 23 Jan 2019
- Completion
- 23 Jan 2019
- Last update posted
- 20 Dec 2019
- Registered enrollment
- 20
- Registry id
- NCT01732861
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.